Item Type | Name |
Academic Article
|
CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
|
Academic Article
|
Composite thymoma and chronic lymphocytic leukemia/small lymphocytic lymphoma involving the anterior mediastinum.
|
Concept
|
Langerhans Cell Sarcoma
|
Concept
|
Leukemia, Hairy Cell
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Lymphoma, T-Cell
|
Concept
|
Cell Movement
|
Concept
|
Leukemia, T-Cell
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Cell Dedifferentiation
|
Concept
|
Langerhans Cells
|
Concept
|
Cell Death
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
Concept
|
Neoplasms, Plasma Cell
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
Concept
|
Epithelial Cells
|
Concept
|
Lymphoma, Extranodal NK-T-Cell
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
Concept
|
Epithelioid Cells
|
Concept
|
Cell Lineage
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily D
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
HeLa Cells
|
Concept
|
Cell Nucleus
|
Concept
|
Cell Division
|
Concept
|
Leukemia, B-Cell
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
Dendritic Cells
|
Concept
|
Lymphoma, Mantle-Cell
|
Concept
|
Cell Cycle Proteins
|
Concept
|
Cell Cycle
|
Concept
|
Cell Membrane
|
Concept
|
Cell Transdifferentiation
|
Concept
|
Clone Cells
|
Concept
|
Myeloid Progenitor Cells
|
Concept
|
Cell Transformation, Neoplastic
|
Concept
|
Carcinoma, Renal Cell
|
Concept
|
Cell Survival
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
Cell Biology
|
Concept
|
Endothelial Cells
|
Concept
|
Germ Cells
|
Concept
|
Lymphoma, T-Cell, Cutaneous
|
Concept
|
Neoplastic Cells, Circulating
|
Concept
|
Lymphoma, Large-Cell, Anaplastic
|
Concept
|
Stem Cell Transplantation
|
Concept
|
Cell Growth Processes
|
Concept
|
Precursor Cells, T-Lymphoid
|
Concept
|
Cell Line
|
Concept
|
Leukemia, Prolymphocytic, B-Cell
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Cell Differentiation
|
Concept
|
Bone Marrow Cells
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Erythroid Cells
|
Concept
|
Histiocytosis, Langerhans-Cell
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Concept
|
Myeloid Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
Carcinoma, Small Cell
|
Concept
|
Cell Line, Tumor
|
Concept
|
Plasma Cells
|
Concept
|
Lymphoma, B-Cell, Marginal Zone
|
Concept
|
Cells, Cultured
|
Concept
|
Stem Cells
|
Concept
|
Cell Hypoxia
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
Concept
|
Cell Proliferation
|
Concept
|
Cell Count
|
Academic Article
|
TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
|
Academic Article
|
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
|
Academic Article
|
Activation status of the JAK/STAT3 pathway in mantle cell lymphoma.
|
Academic Article
|
The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma.
|
Academic Article
|
Ewing sarcoma family of tumors.
|
Academic Article
|
ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma.
|
Academic Article
|
Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases.
|
Academic Article
|
Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
|
Academic Article
|
Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience.
|
Academic Article
|
p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
|
Academic Article
|
Cytogenetic findings in blastoid mantle cell lymphoma.
|
Academic Article
|
Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma.
|
Academic Article
|
Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.
|
Academic Article
|
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells.
|
Academic Article
|
Molecular characterization of the pediatric preclinical testing panel.
|
Academic Article
|
Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
|
Academic Article
|
Met amplification and tumor progression in Cdkn2a-deficient melanocytes.
|
Academic Article
|
Dramatically elevated circulating tumor cell numbers in a patient with small cell neuroendocrine carcinoma of the prostate.
|
Academic Article
|
Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.
|
Academic Article
|
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories.
|
Academic Article
|
Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases.
|
Academic Article
|
Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer.
|
Academic Article
|
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer.
|
Academic Article
|
Epstein-Barr virus-positive plasmacytoma in immunocompetent patients.
|
Academic Article
|
CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.
|
Academic Article
|
Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies.
|
Academic Article
|
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.
|
Academic Article
|
Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of ?d T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With a? T-Cell Large Granular Lymphocytic Leukemia. [corrected].
|
Academic Article
|
Disseminated blastic plasmacytoid dendritic cell neoplasm.
|
Academic Article
|
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study.
|
Academic Article
|
De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
|
Academic Article
|
Hypoxic preconditioning decreases nuclear factor ?B activity via Disrupted in Schizophrenia-1.
|
Academic Article
|
High-grade Transformation of Low-grade B-cell Lymphoma: Pathology and Molecular Pathogenesis.
|
Academic Article
|
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults
|
Academic Article
|
De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated with Poor Prognosis
|
Academic Article
|
Template for reporting results of biomarker testing of specimens from patients with diffuse large B-cell lymphoma, not otherwise specified
|
Academic Article
|
Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia
|
Academic Article
|
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer
|
Academic Article
|
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
|
Academic Article
|
Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms
|
Academic Article
|
High-grade transformation of low-grade B-cell lymphoma
|
Academic Article
|
Simultaneous deletion of 3'ETV6 and 5' EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm
|
Academic Article
|
Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
|
Academic Article
|
Caveolae are negative regulators of transforming growth factor-beta1 signaling in ureteral smooth muscle cells.
|
Academic Article
|
Transcriptional repression of Na-K-2Cl cotransporter NKCC1 by hypoxia-inducible factor-1.
|
Academic Article
|
Methods to assess tissue permeability.
|
Academic Article
|
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation.
|
Academic Article
|
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation.
|
Academic Article
|
MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
|
Academic Article
|
Crystal-storing histiocytosis: a clinicopathological study of 13 cases.
|
Academic Article
|
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
|
Academic Article
|
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
|
Academic Article
|
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
|
Academic Article
|
Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.
|
Academic Article
|
Clinical significance of acquired loss of the X chromosome in bone marrow.
|
Academic Article
|
Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists.
|
Academic Article
|
Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
|
Academic Article
|
Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.
|
Academic Article
|
Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations.
|
Academic Article
|
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.
|
Academic Article
|
Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.
|
Academic Article
|
Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.
|
Academic Article
|
Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
|
Academic Article
|
Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.
|
Academic Article
|
Characteristics and clinical implications of reactive germinal centers in the bone marrow.
|
Academic Article
|
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
|
Academic Article
|
Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence.
|
Academic Article
|
CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation.
|
Academic Article
|
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.
|
Academic Article
|
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
|
Academic Article
|
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
|
Academic Article
|
Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma.
|
Academic Article
|
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.
|
Academic Article
|
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.
|
Academic Article
|
Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
|
Academic Article
|
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
|
Academic Article
|
Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
|
Academic Article
|
Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
|
Academic Article
|
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study.
|
Academic Article
|
Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
|
Academic Article
|
Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms.
|
Academic Article
|
Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement.
|
Academic Article
|
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.
|
Academic Article
|
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.
|
Academic Article
|
Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
|
Academic Article
|
Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.
|
Academic Article
|
Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.
|
Academic Article
|
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
|
Academic Article
|
Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Academic Article
|
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.
|
Academic Article
|
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study.
|
Academic Article
|
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation.
|
Academic Article
|
Targeting nuclear ?-catenin as therapy for post-myeloproliferative neoplasm secondary AML.
|
Academic Article
|
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells.
|
Academic Article
|
Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.
|
Academic Article
|
Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia.
|
Academic Article
|
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.
|
Academic Article
|
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
|
Academic Article
|
Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy.
|
Academic Article
|
Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.
|
Academic Article
|
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
|
Academic Article
|
Unusual case of human herpesvirus 8-positive large B-cell lymphoma associated with Castleman disease.
|
Academic Article
|
Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles.
|
Academic Article
|
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
|
Concept
|
T-Cell Intracellular Antigen-1
|
Concept
|
Programmed Cell Death 1 Receptor
|
Concept
|
Myeloid Cell Leukemia Sequence 1 Protein
|
Academic Article
|
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
|
Academic Article
|
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Academic Article
|
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.
|
Academic Article
|
Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Academic Article
|
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma.
|
Academic Article
|
Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma.
|
Academic Article
|
Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.
|
Academic Article
|
Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications.
|
Academic Article
|
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.
|
Academic Article
|
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma.
|
Academic Article
|
Chronic lymphocytic leukemia with plasmacytic differentiation.
|
Academic Article
|
Epstein - Barr virus infection in de novo diffuse large B-cell lymphoma in Jordan and Turkey.
|
Academic Article
|
Coactivation of NF-?B and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.
|
Academic Article
|
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival.
|
Academic Article
|
Diffuse large B-cell lymphoma variants: an update.
|
Academic Article
|
Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
|
Academic Article
|
Immunopathology of Kikuchi-Fujimoto disease: A reappraisal using novel immunohistochemistry markers.
|
Academic Article
|
MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP?treated diffuse large B-cell lymphoma.
|
Academic Article
|
Reconsideration of the first recognition of breast implant-associated anaplastic large cell lymphoma: A critical review of the literature.
|
Academic Article
|
Mechanistic basis and efficacy of targeting the ?-catenin-TCF7L2-JMJD6-c-Myc axis to overcome resistance to BET inhibitors.
|
Academic Article
|
Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
|
Academic Article
|
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.
|
Academic Article
|
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
|
Academic Article
|
PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
|
Academic Article
|
Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
|
Academic Article
|
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.
|
Academic Article
|
Genomic and Immunophenotypic Landscape of Aggressive NK-Cell Leukemia.
|
Academic Article
|
Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall.
|
Academic Article
|
Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
|
Academic Article
|
Germline DNMT3A mutation in familial acute myeloid leukaemia.
|
Academic Article
|
Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.
|
Academic Article
|
Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
|
Academic Article
|
Aggressive NK Cell Leukemia: Current State of the Art.
|
Academic Article
|
CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma.
|
Academic Article
|
From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
|
Academic Article
|
Pan-RAF Inhibition Shows Anti-Leukemic Activity in RAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells with FLT3 Mutation.
|
Academic Article
|
B acute lymphoblastic leukemia arising during maintenance therapy for multiple myeloma.
|
Academic Article
|
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax.
|
Academic Article
|
T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes.
|
Academic Article
|
Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia.
|
Academic Article
|
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
|
Academic Article
|
TAM kinases as regulators of cell death.
|
Academic Article
|
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma.
|
Academic Article
|
From the archives of MD Anderson Cancer Center: A case of concurrent follicular lymphoma and Langerhans cell sarcoma with a review of the literature.
|
Academic Article
|
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
|
Academic Article
|
Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors.
|
Academic Article
|
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia.
|
Academic Article
|
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy.
|
Academic Article
|
Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.
|
Academic Article
|
CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations.
|
Academic Article
|
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.
|
Academic Article
|
Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm.
|
Academic Article
|
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.
|
Academic Article
|
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
|
Academic Article
|
B-prolymphocytic leukemia: Is it time to retire this entity?
|
Academic Article
|
Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon.
|
Academic Article
|
Development of TP53 mutations over the course of therapy for acute myeloid leukemia.
|
Academic Article
|
B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
|
Academic Article
|
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse.
|
Academic Article
|
Artificial intelligence strategy integrating morphologic and architectural biomarkers provides robust diagnostic accuracy for disease progression in chronic lymphocytic leukemia.
|
Academic Article
|
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience.
|
Academic Article
|
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.
|
Academic Article
|
Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow.
|
Academic Article
|
Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
|
Academic Article
|
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.
|
Academic Article
|
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Academic Article
|
The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis.
|
Academic Article
|
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
|
Academic Article
|
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
|
Academic Article
|
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c).
|
Academic Article
|
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.
|
Academic Article
|
Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia.
|
Academic Article
|
From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells.
|
Academic Article
|
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.
|
Academic Article
|
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
|
Academic Article
|
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.
|
Academic Article
|
Prediction of survival with intensive chemotherapy in acute myeloid leukemia.
|
Academic Article
|
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse.
|
Academic Article
|
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms.
|
Academic Article
|
MUM1/IRF4 is Highly Expressed in Dermatopathic Lymphadenopathy: Potential Utility in Diagnosis and Differential Diagnosis.
|
Academic Article
|
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
|
Academic Article
|
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update.
|
Academic Article
|
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix? PC1 System.
|
Academic Article
|
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
|
Academic Article
|
Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.
|
Academic Article
|
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
|
Academic Article
|
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
|
Academic Article
|
Allogeneic cord blood regulatory T cells can resolve lung inflammation.
|
Academic Article
|
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.
|
Academic Article
|
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1.
|
Academic Article
|
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma?variant.
|
Academic Article
|
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
|
Academic Article
|
Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
|
Academic Article
|
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.
|
Academic Article
|
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.
|
Academic Article
|
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
|
Academic Article
|
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
|
Academic Article
|
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
|
Academic Article
|
ZNF683 marks a CD8+ T?cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
|
Academic Article
|
Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies.
|
Academic Article
|
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.
|
Academic Article
|
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression.
|
Academic Article
|
The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.
|
Academic Article
|
Myelodysplastic neoplasms evolving from inherited bone marrow failure syndromes / germline predisposition syndromes: Back under the microscope.
|
Academic Article
|
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL.
|